Salvage radiotherapy after prostatectomy - What is the best time to treat?

Radiotherapy and Oncology

Volumn 103, Issue 2, 2012, Pages 239-243

  Siegmann, Alessandra ^a   Bottke, Dirk ^b   Faehndrich, Julia ^a   Brachert, Maike ^b   Lohm, Gunnar ^a   Miller, Kurt ^a   Bartkowiak, Detlef ^b   Hinkelbein, Wolfgang ^a   Wiegel, Thomas ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Biochemical relaps; Prostate cancer; PSA; Salvage radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CYSTITIS; FOLLOW UP; GLEASON SCORE; HUMAN; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION FIELD; RECTUM HEMORRHAGE; RETROSPECTIVE STUDY; SALVAGE THERAPY; SKIN METASTASIS; TENESMUS; URETHRA STRICTURE;

AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TIME FACTORS;

EID: 84860443147     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.10.024     Document Type: Article

References (31)

1. F.K. Chun, M. Graefen, and M. Zacharias Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer World J Urol 24 2006 273 280
2. P. Swindle, J.A. Eastham, and M. Ohori Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens J Urol 179 2008 S47 51
3. F. Pinto, T. Prayer-Galetti, and M. Gardiman Clinical and pathological characteristics of patients presenting with biochemical progression after radical retropubic prostatectomy for pathologically organ-confined prostate cancer Urol Int 76 2006 202 208
4. K.A. Roehl, M. Han, and C.G. Ramos Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3, 478 consecutive patients: long-term results J Urol 172 2004 910 914
5. B. Shekarriz, J. Upadhyay, and D.P. Wood Jr. Vesicourethral anastomosis biopsy after radical prostatectomy: predictive value of prostate-specific antigen and pathologic stage Urology 54 1999 1044 1048
6. R.G. Cremers, E.N. van Lin, and W.L. Gerrits Efficacy and tolerance of salvage radiotherapy after radical prostatectomy, with emphasis on high-risk patients suited for adjuvant radiotherapy Radiother Oncol 97 2010 467 473
7. T. Budiharto, C. Perneel, and K. Haustermans A multi-institutional analysis comparing adjuvant and salvage radiation therapy for high-risk prostate cancer patients with undetectable PSA after prostatectomy Radiother Oncol 97 2010 474 479
8. T.M. Pisansky, T.F. Kozelsky, and R.P. Myers Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer J Urol 163 2000 845 850
9. J.F. Pazona, M. Han, S.A. Hawkins, and K.A. Roehl Salvage radiation therapy for prostate specific antigen progression following radical prostatectomy: 10-year outcome estimates J Urol 174 2005 1282 1286
10. A.J. Stephenson, S.F. Shariat, and M.J. Zelefsky Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy JAMA 291 2004 1325 1332
11. J.F. Ward, H. Zincke, and E.J. Bergstralh Prostate specific antigen doubling time subsequent to radical prostatectomy as a prognosticator of outcome following salvage radiotherapy J Urol 172 2004 2244 2248
12. A.J. Stephenson, P.T. Scardino, and M.W. Kattan Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy J Clin Oncol 25 2007 2035 2041
13. J.J. Coen, A.L. Zietman, and H. Thakral Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases J Clin Oncol 20 2002 3199 3205
14. T. Wiegel, G. Lohm, and D. Bottke Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome-results of a retrospective study Int J Radiat Oncol Biol Phys 73 2009 1009 1016
15. M.S. Anscher, R. Clough, and R. Dodge Radiotherapy for a rising prostate-specific antigen after radical prostatectomy: the first 10 years Int J Radiat Oncol Biol Phys 48 2000 369 375
16. S.E. Schild, S.J. Buskirk, and W.W. Wong The use of radiotherapy for patients with isolated elevation of serum prostate specific antigen following radical prostatectomy J Urol 156 1996 1725 1729
17. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Ass 53 1958 457 462
18. O.K. Macdonald, S.E. Schild, and S.A. Vora Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy J Urol 170 2003 1833 1837
19. M.M. Morris, K.C. Dallow, and A.L. Zietman Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer Int J Radiat Oncol Biol Phys 38 1997 731 736
20. T. Martin, F. Wenz, and D. Bohmer Radiation therapy for prostate cancer in the new S3 guideline. Part 2: postoperative radiation therapy and brachytherapy Urologe A 49 2010 216 220
21. F. Wenz, T. Martin, and D. Bohmer The German S3 guideline prostate cancer: aspects for the radiation oncologist Strahlenther Onkol 186 2010 531 534
22. A.K. Chawla, H.K. Thakral, and A.L. Zietman Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: analysis of efficacy and prognostic factors Urology 59 2002 726 731
23. M. Bolla, H. van Poppel, and L. Collette Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) Lancet 366 2005 572 578
24. D. Bottke, and T. Wiegel Adjuvant radiotherapy after radical prostatectomy: indications, results and side effects Urol Int 78 2007 193 197
25. I.M. Thompson, C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial J Urol 181 2009 956 962
26. T. Wiegel, D. Bottke, and U. Steiner Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95 J Clin Oncol 27 2009 2924 2930
27. M.L. Sautter-Bihl, F. Sedlmayer, and T. Wiegel Postoperative radiotherapy for advanced prostate cancer: improved local control translates into increased survival Strahlenther Onkol 185 2009 485 487
28. D. Bottke, P.A. Abrahamsson, and B. Welte Adjuvant radiotherapy after radical prostatectomy Eur J Cancer Suppl 5 2007 171 176
29. J.L. Peterson, S.J. Buskirk, and M.G. Heckman Late toxicity after postprostatectomy salvage radiation therapy Radiother Oncol 93 2009 203 206
30. M. Abdel-Wahab, I.M. Reis, and K. Hamilton Second primary cancer after radiotherapy for prostate cancer-a seer analysis of brachytherapy versus external beam radiotherapy Int J Radiat Oncol Biol Phys 72 2008 58 68
31. B. Welte, P. Suhr, and D. Bottke Second malignancies in high-dose areas of previous tumor radiotherapy Strahlenther Onkol 186 2010 174 179